菜单

Supply Chain Intelligence about:

Sanofi Aventis

企业页面   United States

See Sanofi Aventis's products and suppliers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

以公司为组织的美国海关记录

70 U.S. shipments available for Sanofi Aventis, updated weekly since 2007
日期 供应商 客户 详细信息 43 more fields
2020-04-17 Sanofi Winthrop Industrie
Sanofi Aventis
XXXXXXXXXXXXXX XX XXXXXXXXXX XXX XXXXXX XXX XXXXXX
货运提单
2020-04-17 Sanofi Winthrop Industrie
Sanofi Aventis
XXXXXXXXXXXXXX XX XXXXXXXXXX XXX XXXXXX XXX XXXXXX
货运提单
2020-04-17 Sanofi Winthrop Industrie
Sanofi Aventis
XXXXXXXXXXXXXX XX XXXXXX XXX XXXXXX XXX XXXXXX
货运提单
货运数据显示一个公司交易什么产品或者更多。 了解更多信息

Explore trading relationships hidden in supply chain data

Contact information for Sanofi Aventis

 
地址
55 CORPORATE DRIVE BRIDGEWATER, NJ 08807
 
 

Sample Bill of Lading

70 shipment records available

Date
2020-04-17
Shipper Name
Sanofi Winthrop Industrie S.A.
Shipper Address
20 AV RAYMOND ANTONY/PARIS 92 92165 FRANCE
Consignee Name
Sanofi Aventis Us Llc
Consignee Address
55 CORPORATE DRIVE BRIDGEWATER, NJ 08807
Notify Party Name
Sanofi Aventis Us Llc
Notify Party Address
55 CORP DRIVE, BRIDGEWATER NJ08807 US
Weight
10620
Weight Unit
KG
Weight in KG
10620.0
Quantity
40
Quantity Unit
PKG
Shipment Origin
France
Details
10,620.0 kg
From port: Genoa, Italy
To port: Georgia Ports Authority, Savannah, Georgia
Place of Receipt
Antony
Foreign Port of Lading
Genoa, Italy
U.S. Port of Unlading
Georgia Ports Authority, Savannah, Georgia
U.S. Destination Port
Georgia Ports Authority, Savannah, Georgia
Commodity
XXXXXXXXXXXXXX XX XXXXXXXXXX XXX XXXXXX XXX XXXXXX
Container
TEMU9300494
Marks Description
XXXXXX XXXXXXX XXXXXX XXXXX XXX XXXX XXXXXXXXXX XXXX XXXXXXXXXX XXXX XXXXXXXXXX
Carrier Name
DANMAR LINES LTD
Vessel Name
MAERSK KLEVEN
Voyage Number
11W
Bill of Lading Number
DMALMILXF0318429
Master Bill of Lading Number
MEDULN067011
Lloyd's Code
9085546
HTS Codes
HTS 3004.90

Recent Panjiva Research about Sanofi Aventis

20161202-insulin-us

Novo and Lilly Face Tough Growth in Diabetes, Trade Data Shows

The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →